{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T03:25:27Z","timestamp":1794799527945,"version":"4.9.1"},"reference-count":162,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007525","name":"Universit\u00e9 de Rennes 1","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007525","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence nationale de la recherche","doi-asserted-by":"publisher","award":["ANR-16-CE18-0010"],"award-info":[{"award-number":["ANR-16-CE18-0010"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.clinre.2025.102529","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T17:49:38Z","timestamp":1736444978000},"page":"102529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Mitochondrial dysfunction in drug-induced hepatic steatosis: Recent findings and current concept"],"prefix":"10.1016","volume":"49","author":[{"given":"Annie","family":"Borgne-Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2994-5465","authenticated-orcid":false,"given":"Bernard","family":"Fromenty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.clinre.2025.102529_bib0001","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/elps.201700079","article-title":"A lipidomic cell-based assay for studying drug-induced phospholipidosis and steatosis","volume":"38","author":"Garc\u00eda-Ca\u00f1averas","year":"2017","journal-title":"Electrophoresis"},{"key":"10.1016\/j.clinre.2025.102529_bib0002","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0399-8320(04)95062-2","article-title":"Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs","volume":"28","author":"Biour","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.clinre.2025.102529_bib0003","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2025.102529_bib0004","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0163-7258(95)00012-6","article-title":"Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity","volume":"67","author":"Fromenty","year":"1995","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.clinre.2025.102529_bib0005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cld.2013.07.012","article-title":"Drug-induced steatohepatitis","volume":"17","author":"Patel","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinre.2025.102529_bib0006","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.livres.2019.06.001","article-title":"Inhibition of mitochondrial fatty acid oxidation in drug-induced hepatic steatosis","volume":"3","author":"Fromenty","year":"2019","journal-title":"Liver Res"},{"issue":"10","key":"10.1016\/j.clinre.2025.102529_bib0007","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.3390\/ijms25105203","article-title":"Drug-induced fatty liver disease (DIFLD): a comprehensive analysis of clinical, biochemical, and histopathological data for mechanisms identification and consistency with current adverse outcome pathways","volume":"25","author":"L\u00f3pez-Pascual","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.clinre.2025.102529_bib0008","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.clinre.2025.102529_bib0009","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3390\/biomedicines8110526","article-title":"Mitochondria at work: new insights into regulation and dysregulation of cellular energy supply and metabolism","volume":"8","author":"Schirrmacher","year":"2020","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2025.102529_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.110916","article-title":"Alteration of mitochondrial DNA homeostasis in drug-induced liver injury","volume":"135","author":"Fromenty","year":"2020","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.clinre.2025.102529_bib0012","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","article-title":"The biochemistry and physiology of mitochondrial fatty acid \u03b2-oxidation and its genetic disorders","volume":"78","author":"Houten","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.clinre.2025.102529_bib0013","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mito.2018.02.009","article-title":"Mitochondrial \u03b2-oxidation of saturated fatty acids in humans","volume":"46","author":"Adeva-Andany","year":"2019","journal-title":"Mitochondrion"},{"key":"10.1016\/j.clinre.2025.102529_bib0014","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biochi.2022.03.013","article-title":"Regulation of mitochondrial function by forkhead transcription factors","volume":"198","author":"Jerome","year":"2022","journal-title":"Biochimie"},{"issue":"15","key":"10.1016\/j.clinre.2025.102529_bib0015","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.3390\/ijms21155266","article-title":"Roles of mitochondrial sirtuins in mitochondrial function, redox homeostasis, insulin resistance and type 2 diabetes","volume":"21","author":"Wang","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0016","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","article-title":"New insights into activation and function of the AMPK","volume":"24","author":"Steinberg","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"10.1016\/j.clinre.2025.102529_bib0017","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1111\/jcmm.15194","article-title":"Mitochondrial biogenesis: an update","volume":"24","author":"Popov","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0018","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12929-023-00975-7","article-title":"Crosstalk between mitochondrial biogenesis and mitophagy to maintain mitochondrial homeostasis","volume":"30","author":"Liu","year":"2023","journal-title":"J Biomed Sci"},{"issue":"5","key":"10.1016\/j.clinre.2025.102529_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbabio.2022.148554","article-title":"Mitochondrial DNA replication and repair defects: clinical phenotypes and therapeutic interventions","volume":"1863","author":"Roy","year":"2022","journal-title":"Biochim Biophys Acta Bioenerg"},{"issue":"22","key":"10.1016\/j.clinre.2025.102529_bib0020","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1093\/hmg\/10.22.2469","article-title":"Selection of a mtDNA sequence variant in hepatocytes of heteroplasmic mice is not due to differences in respiratory chain function or efficiency of replication","volume":"10","author":"Battersby","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1016\/j.clinre.2025.102529_bib0021","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/antiox9100980","article-title":"Roles of Nrf2 in liver diseases: molecular, pharmacological, and epigenetic aspects","volume":"9","author":"Galicia-Moreno","year":"2020","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107159","article-title":"Fatty acid oxidation drives mitochondrial hydrogen peroxide production by \u03b1-ketoglutarate dehydrogenase","volume":"300","author":"Grayson","year":"2024","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2025.102529_bib0023","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.redox.2015.02.003","article-title":"H2O2 release from the very long chain acyl-CoA dehydrogenase","volume":"4","author":"Kakimoto","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.clinre.2025.102529_bib0024","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-nutr-111120-111518","article-title":"Metabolic and signaling roles of ketone bodies in health and disease","volume":"41","author":"Puchalska","year":"2021","journal-title":"Annu Rev Nutr"},{"issue":"8","key":"10.1016\/j.clinre.2025.102529_bib0025","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41418-023-01187-0","article-title":"Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions","volume":"30","author":"Bernardi","year":"2023","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0026","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/03602532.2011.604086","article-title":"Central role of mitochondria in drug-induced liver injury","volume":"44","author":"Pessayre","year":"2012","journal-title":"Drug Metab Rev"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0027","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/cells11020288","article-title":"Role of mitochondrial cytochrome P450 2E1 in healthy and diseased liver","volume":"11","author":"Massart","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.clinre.2025.102529_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1264530","article-title":"The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response","volume":"14","author":"Jena","year":"2023","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0029","first-page":"e0361","article-title":"Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases","volume":"8","author":"Van Hove","year":"2024","journal-title":"Hepatol Commun"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0030","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2025.102529_bib0031","doi-asserted-by":"crossref","first-page":"789","DOI":"10.5604\/16652681.1171749","article-title":"Drug-induced fatty liver disease: an overview of pathogenesis and management","volume":"14","author":"Satapathy","year":"2015","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0032","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/toxsci\/kfae055","article-title":"Drug-induced impairment of mitochondrial fatty acid oxidation and steatosis: assessment of causal relationship with 45 pharmaceuticals","volume":"200","author":"Buron","year":"2024","journal-title":"Toxicol Sci"},{"issue":"5","key":"10.1016\/j.clinre.2025.102529_bib0033","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/135965350300800514","article-title":"Uridine abrogates mitochondrial toxicity related to nucleoside analogue reverse transcriptase inhibitors in HepG2 cells","volume":"8","author":"Walker","year":"2003","journal-title":"Antivir Ther"},{"issue":"3","key":"10.1016\/j.clinre.2025.102529_bib0034","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/jpet.117.246751","article-title":"Drug-induced alterations of mitochondrial DNA homeostasis in steatotic and nonsteatotic HepaRG cells","volume":"365","author":"Le Guillou","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1472-8206.2008.00608.x","article-title":"Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies","volume":"22","author":"Labbe","year":"2008","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0036","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s00394-019-02017-1","article-title":"Moderate chronic ethanol consumption exerts beneficial effects on nonalcoholic fatty liver in mice fed a high-fat diet: possible role of higher formation of triglycerides enriched in monounsaturated fatty acids","volume":"59","author":"Bucher","year":"2020","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clinre.2025.102529_bib0037","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphys.2020.01048","article-title":"Alcohol and liver clock disruption increase small droplet macrosteatosis, alter lipid metabolism and clock gene mRNA rhythms, and remodel the triglyceride lipidome in mouse liver","volume":"11","author":"Valcin","year":"2020","journal-title":"Front Physiol"},{"issue":"6","key":"10.1016\/j.clinre.2025.102529_bib0038","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.2008.058248","article-title":"Histological patterns in drug-induced liver disease","volume":"62","author":"Ramachandran","year":"2009","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0039","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5858\/arpa.2019-0341-RA","article-title":"Fatty liver disease: a practical approach","volume":"144","author":"Mostafa","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13256-018-1629-8","article-title":"Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports","volume":"12","author":"Tsuda","year":"2018","journal-title":"J Med Case Rep"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0041","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/1440-1681.12861","article-title":"Co-ingestion of aspirin and acetaminophen promoting fulminant liver failure: a critical review of Reye syndrome in the current perspective at the dawn of the 21st century","volume":"45","author":"Dinakaran","year":"2018","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"10","key":"10.1016\/j.clinre.2025.102529_bib0042","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1083\/jcb.201803153","article-title":"Lipid droplet size directs lipolysis and lipophagy catabolism in hepatocytes","volume":"218","author":"Schott","year":"2019","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0043","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15548627.2021.1895658","article-title":"The m\u00e9nage \u00e0 trois of autophagy, lipid droplets and liver disease","volume":"18","author":"Filali-Mouncef","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.clinre.2025.102529_bib0044","series-title":"Liver pathology","first-page":"240","article-title":"Drug-induced microvesicular steatosis","author":"Kleiner","year":"2011"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/metabo11010051","article-title":"l-carnitine and acylcarnitines: mitochondrial biomarkers for precision medicine","volume":"11","author":"McCann","year":"2021","journal-title":"Metabolites"},{"issue":"6","key":"10.1016\/j.clinre.2025.102529_bib0046","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jhep.2018.02.006","article-title":"Paediatric fatty liver disease (PeFLD): all is not NAFLD - Pathophysiological insights and approach to management","volume":"68","author":"Hegarty","year":"2018","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0047","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/apt.18059","article-title":"Review article: hepatic steatosis and its associations with acute and chronic liver diseases","volume":"60","author":"Koenig","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.clinre.2025.102529_bib0048","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/tpj.2013.39","article-title":"Data mining reveals a network of early-response genes as a consensus signature of drug-induced in vitro and in vivo toxicity","volume":"14","author":"Zhang","year":"2014","journal-title":"Pharmacogenomics J"},{"issue":"6","key":"10.1016\/j.clinre.2025.102529_bib0049","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s13318-018-0479-5","article-title":"In vitro monitoring of the mitochondrial beta-oxidation flux of palmitic acid and investigation of its pharmacological alteration by therapeutics","volume":"43","author":"Murgasova","year":"2018","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"6","key":"10.1016\/j.clinre.2025.102529_bib0050","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.3390\/ijms23063315","article-title":"Mitochondria as the target of hepatotoxicity and drug-induced liver injury: molecular mechanisms and detection methods","volume":"23","author":"Mihajlovic","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.clinre.2025.102529_bib0051","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0022-3565(25)22965-2","article-title":"Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II","volume":"255","author":"Fromenty","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0052","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.tiv.2008.01.011","article-title":"High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes","volume":"22","author":"Igoudjil","year":"2008","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"10.1016\/j.clinre.2025.102529_bib0053","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.21635","article-title":"Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure","volume":"45","author":"Chen","year":"2007","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.clinre.2025.102529_bib0054","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/antiox13070832","article-title":"N-acetyl cysteine overdose induced acute toxicity and hepatic microvesicular steatosis by disrupting gsh and interfering lipid metabolisms in normal mice","volume":"13","author":"Tsai","year":"2024","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.clinre.2025.102529_bib0055","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1096\/fj.201802015R","article-title":"Augmenter of liver regeneration protein deficiency promotes hepatic steatosis by inducing oxidative stress and microRNA-540 expression","volume":"33","author":"Kumar","year":"2019","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.clinre.2025.102529_bib0056","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1530-0277.2002.tb02621.x","article-title":"Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion","volume":"26","author":"Cahill","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"issue":"39","key":"10.1016\/j.clinre.2025.102529_bib0057","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","article-title":"Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease","volume":"20","author":"Paradies","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clinre.2025.102529_bib0058","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1381612825666190329145428","article-title":"Valproic acid and the liver injury in patients with epilepsy: an update","volume":"25","author":"Guo","year":"2019","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0059","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0028-1091980","article-title":"Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease","volume":"28","author":"Malhi","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"9","key":"10.1016\/j.clinre.2025.102529_bib0060","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1194\/jlr.M083741","article-title":"Oxidized linoleic acid metabolites induce liver mitochondrial dysfunction, apoptosis, and NLRP3 activation in mice","volume":"59","author":"Schuster","year":"2018","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.clinre.2025.102529_bib0061","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.freeradbiomed.2008.04.029","article-title":"Fatty acids as modulators of the cellular production of reactive oxygen species","volume":"45","author":"Sch\u00f6nfeld","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0062","doi-asserted-by":"crossref","first-page":"e12404","DOI":"10.1111\/jpi.12404","article-title":"Melatonin protects against lipid-induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice","volume":"62","author":"Das","year":"2017","journal-title":"J Pineal Res"},{"issue":"6","key":"10.1016\/j.clinre.2025.102529_bib0063","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jhep.2021.01.045","article-title":"Diagnosis and management of secondary causes of steatohepatitis","volume":"74","author":"Liebe","year":"2021","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0064","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-2002-30106","article-title":"Drugs and steatohepatitis","volume":"22","author":"Farrell","year":"2002","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0034-1375960","article-title":"Drug-induced hepatic steatosis","volume":"34","author":"Amacher","year":"2014","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0066","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0067","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41584-022-00883-4","article-title":"Busting the myth of methotrexate chronic hepatotoxicity","volume":"19","author":"Di Martino","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0068","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10565-020-09537-1","article-title":"Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity","volume":"37","author":"Allard","year":"2021","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0069","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/biomedicines10010194","article-title":"Detailed molecular mechanisms involved in drug-induced non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: an update","volume":"10","author":"Di Pasqua","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.clinre.2025.102529_bib0070","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3389\/fgene.2019.01007","article-title":"Mining public toxicogenomic data reveals insights and challenges in delineating liver steatosis adverse outcome pathways","volume":"10","author":"AbdulHameed","year":"2019","journal-title":"Front Genet"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0071","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0016-5085(98)70590-6","article-title":"Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes","volume":"114","author":"Berson","year":"1998","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.clinre.2025.102529_bib0072","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2353\/ajpath.2009.090332","article-title":"Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice","volume":"175","author":"Mitchell","year":"2009","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0073","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.32731","article-title":"Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis","volume":"77","author":"Loureiro","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2025.102529_bib0074","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3389\/fphar.2018.00453","article-title":"Mitochondrial-lysosomal axis in acetaminophen hepatotoxicity","volume":"9","author":"Moles","year":"2018","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.clinre.2025.102529_bib0075","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/hep.24290","article-title":"Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells","volume":"53","author":"Anth\u00e9rieu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2025.102529_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113860","article-title":"Valproic acid affects fatty acid and triglyceride metabolism in HepaRG cells exposed to fatty acids by different mechanisms","volume":"177","author":"Gr\u00fcnig","year":"2020","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0077","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12859-024-05845-z","article-title":"A strategy to detect metabolic changes induced by exposure to chemicals from large sets of condition-specific metabolic models computed with enumeration techniques","volume":"25","author":"Fresnais","year":"2024","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0078","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/jhep.2003.50309","article-title":"Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice","volume":"38","author":"Lett\u00e9ron","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2025.102529_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152585","article-title":"Involvement of CYP2E1-ROS-CD36\/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro","volume":"445","author":"Ma","year":"2020","journal-title":"Toxicology"},{"issue":"11","key":"10.1016\/j.clinre.2025.102529_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294363","article-title":"Probiotics attenuate valproate-induced liver steatosis and oxidative stress in mice","volume":"18","author":"Song","year":"2023","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.clinre.2025.102529_bib0081","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s42255-021-00489-2","article-title":"Peroxisomal \u03b2-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis","volume":"3","author":"Ding","year":"2021","journal-title":"Nat Metab"},{"issue":"9","key":"10.1016\/j.clinre.2025.102529_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105174","article-title":"Long-chain dicarboxylic acids play a critical role in inducing peroxisomal beta-oxidation and hepatic triacylglycerol accumulation","volume":"299","author":"Zhang","year":"2023","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.clinre.2025.102529_bib0083","doi-asserted-by":"crossref","first-page":"e13347","DOI":"10.1111\/jne.13347","article-title":"Metabolic effects of atypical antipsychotics: molecular targets","volume":"35","author":"Fonseca","year":"2023","journal-title":"J Neuroendocrinol"},{"issue":"5","key":"10.1016\/j.clinre.2025.102529_bib0084","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3390\/biomedicines11051499","article-title":"Valproate-induced metabolic syndrome","volume":"11","author":"Shnayder","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.clinre.2025.102529_bib0085","doi-asserted-by":"crossref","first-page":"G298","DOI":"10.1152\/ajpgi.00458.2020","article-title":"Repetitive amiodarone administration causes liver damage via adipose tissue ER stress-dependent lipolysis, leading to hepatotoxic free fatty acid accumulation","volume":"321","author":"Hubel","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"10.1016\/j.clinre.2025.102529_bib0086","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/acer.14698","article-title":"A review of the role of ethanol-induced adipose tissue dysfunction in alcohol-associated liver disease","volume":"45","author":"Gopal","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"10.1016\/j.clinre.2025.102529_bib0087","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/hep.32675","article-title":"Adipose lipolysis is important for ethanol to induce fatty liver in the National Institute on Alcohol Abuse and Alcoholism murine model of chronic and binge ethanol feeding","volume":"77","author":"Mathur","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2025.102529_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101134","article-title":"Mitochondrial oxidative function in NAFLD: friend or foe?","volume":"50","author":"Shum","year":"2021","journal-title":"Mol Metab"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0089","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12072-023-10633-7","article-title":"Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update","volume":"18","author":"Mao","year":"2024","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0090","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/toxsci\/KFS197","article-title":"Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria","volume":"129","author":"Porceddu","year":"2012","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0091","first-page":"75","article-title":"Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives","volume":"4","author":"Ramachandran","year":"2018","journal-title":"J Clin Transl Res"},{"issue":"3","key":"10.1016\/j.clinre.2025.102529_bib0092","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pharmrev.122.000568","article-title":"Time to change: a systems pharmacology approach to disentangle mechanisms of drug-induced mitochondrial toxicity","volume":"75","author":"Hoogstraten","year":"2023","journal-title":"Pharmacol Rev"},{"issue":"9","key":"10.1016\/j.clinre.2025.102529_bib0093","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/apt.14952","article-title":"Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease - a physiopathological and clinical integrated view","volume":"48","author":"Bessone","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2025.102529_bib0094","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/bs.apha.2019.01.003","article-title":"Drug-induced liver injury in obesity and nonalcoholic fatty liver disease","volume":"85","author":"Allard","year":"2019","journal-title":"Adv Pharmacol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/livers3010003","article-title":"Acetaminophen-induced hepatotoxicity in obesity and nonalcoholic fatty liver disease: a critical review","volume":"3","author":"Begriche","year":"2023","journal-title":"Livers"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0096","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/hep.21687","article-title":"Effects of rosiglitazone on the liver histology and mitochondrial function in ob\/ob mice","volume":"46","author":"Garc\u00eda-Ruiz","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0097","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.hepres.2005.12.001","article-title":"Development of nonalcoholic steatohepatitis model through combination of high-fat diet and tetracycline with morbid obesity in mice","volume":"34","author":"Ito","year":"2006","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinre.2025.102529_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108399","article-title":"Olanzapine-induced liver injury in mice: aggravation by high-fat diet and protection with sulforaphane","volume":"81","author":"Isaacson","year":"2020","journal-title":"J Nutr Biochem"},{"issue":"3","key":"10.1016\/j.clinre.2025.102529_bib0099","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/ijms23031062","article-title":"Xenobiotic-induced aggravation of metabolic-associated fatty liver disease","volume":"23","author":"Massart","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.clinre.2025.102529_bib0100","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.therap.2019.10.001","article-title":"Polypharmacy: a general review of definitions, descriptions and determinants","volume":"75","author":"Guillot","year":"2020","journal-title":"Therapie"},{"issue":"3","key":"10.1016\/j.clinre.2025.102529_bib0101","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jhep.2010.12.034","article-title":"Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK","volume":"55","author":"Xu","year":"2011","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2025.102529_bib0102","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/hep4.1698","article-title":"An experimental DUAL model of advanced liver damage","volume":"5","author":"Bened\u00e9-Ubieto","year":"2021","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0103","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/biomedicines11010015","article-title":"Treatment of drug-induced liver injury","volume":"11","author":"Teschke","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.clinre.2025.102529_bib0104","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105404","article-title":"Prevention and management of idiosyncratic drug-induced liver injury: systematic review and meta-analysis of randomised clinical trials","volume":"164","author":"Niu","year":"2021","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"issue":"5","key":"10.1016\/j.clinre.2025.102529_bib0106","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.3390\/ijms23052717","article-title":"The role of l-carnitine in mitochondria, prevention of metabolic inflexibility and disease initiation","volume":"23","author":"Virmani","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.clinre.2025.102529_bib0107","doi-asserted-by":"crossref","first-page":"e0425","DOI":"10.1097\/HC9.0000000000000425","article-title":"Potential utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction-associated steatohepatitis","volume":"8","author":"Lyu","year":"2024","journal-title":"Hepatol Commun"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0108","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15563650902752376","article-title":"Carnitine in the treatment of valproic acid-induced toxicity","volume":"47","author":"Lheureux","year":"2009","journal-title":"Clin Toxicol"},{"issue":"10","key":"10.1016\/j.clinre.2025.102529_bib0109","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1212\/WNL.56.10.1405","article-title":"Effect of l-carnitine treatment for valproate-induced hepatotoxicity","volume":"56","author":"Bohan","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.clinre.2025.102529_bib0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/135965350701200314","article-title":"High doses of stavudine induce fat wasting and mild liver damage without impairing mitochondrial respiration in mice","volume":"12","author":"Igoudjil","year":"2007","journal-title":"Antivir Ther"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0111","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/acer.14568","article-title":"Carnitine in alcohol use disorders: a scoping review","volume":"45","author":"Bota","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0112","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.etp.2007.02.009","article-title":"Hepatoprotective effect of l-carnitine against acute acetaminophen toxicity in mice","volume":"59","author":"Yapar","year":"2007","journal-title":"Exp Toxicol Pathol"},{"issue":"5","key":"10.1016\/j.clinre.2025.102529_bib0113","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/jgh.12474","article-title":"Carnitine for prevention of antituberculosis drug-induced hepatotoxicity: a randomized, clinical trial","volume":"29","author":"Hatamkhani","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2025.102529_bib0114","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00580-019-03045-3","article-title":"The protective role of l-carnitine against 1st-and 2nd-generation antihistamine-induced liver injury in mice","volume":"29","author":"Abdel-Emam","year":"2020","journal-title":"Comp Clin Path"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.arcmed.2019.12.005","article-title":"Effect of l-carnitine supplementation on liver enzymes: a systematic review and meta-analysis of randomized controlled trials","volume":"51","author":"Askarpour","year":"2020","journal-title":"Arch Med Res"},{"key":"10.1016\/j.clinre.2025.102529_bib0116","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2019.102273","article-title":"The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"48","author":"Abolfathi","year":"2020","journal-title":"Complement Ther Med"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0117","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13643-023-02238-w","article-title":"Efficacy and safety of carnitine supplementation on NAFLD: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2023","journal-title":"Syst Rev"},{"key":"10.1016\/j.clinre.2025.102529_bib0118","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110258","article-title":"Fatal acetaminophen poisoning with hepatic microvesicular steatosis in a child after repeated administration of therapeutic doses","volume":"310","author":"Bouvet","year":"2020","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.clinre.2025.102529_bib0119","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.876868","article-title":"N-acetylcysteine for the management of non-acetaminophen drug-induced liver injury in adults: a systematic review","volume":"13","author":"Sanabria-Cabrera","year":"2022","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.clinre.2025.102529_bib0120","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/antiox9121283","article-title":"N-acetyl cysteine targets hepatic lipid accumulation to curb oxidative stress and inflammation in NAFLD: a comprehensive analysis of the literature","volume":"9","author":"Dludla","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.clinre.2025.102529_bib0121","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9949453","article-title":"N-Acetylcysteine: a review of clinical usefulness (an old drug with new tricks)","volume":"2021","author":"Schwalfenberg","year":"2021","journal-title":"J Nutr Metab"},{"key":"10.1016\/j.clinre.2025.102529_bib0122","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.fct.2012.09.021","article-title":"A review on antioxidants, prooxidants and related controversy: natural and synthetic compounds, screening and analysis methodologies and future perspectives","volume":"51","author":"Carocho","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.clinre.2025.102529_bib0123","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12970-018-0221-3","article-title":"Effects of hydroxytyrosol dose on the redox status of exercised rats: the role of hydroxytyrosol in exercise performance","volume":"15","author":"Al Fazazi","year":"2018","journal-title":"J Int Soc Sports Nutr"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0124","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10545-015-9871-3","article-title":"Mitochondrial trifunctional protein deficiency in human cultured fibroblasts: effects of bezafibrate","volume":"39","author":"Djouadi","year":"2016","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.clinre.2025.102529_bib0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mito.2019.10.010","article-title":"The changing landscape of clinical trials for mitochondrial diseases: 2011 to present","volume":"50","author":"Khayat","year":"2020","journal-title":"Mitochondrion"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0126","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40291-020-00510-6","article-title":"Current and emerging clinical treatment in mitochondrial disease","volume":"25","author":"Tinker","year":"2021","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.clinre.2025.102529_bib0127","article-title":"Thyroid hormone receptor-\u03b2 analogues for the treatment of metabolic dysfunction-associated steatohepatitis (MASH)","author":"Ratziu","year":"2024","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0128","doi-asserted-by":"crossref","first-page":"60","DOI":"10.17925\/EE.2023.19.1.60","article-title":"Resmetirom: an orally administered, small molecule, liver-directed, beta-selective THR agonist for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"19","author":"Karim","year":"2023","journal-title":"touchREV Endocrinol"},{"issue":"11","key":"10.1016\/j.clinre.2025.102529_bib0129","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","article-title":"The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic","volume":"16","author":"Geng","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/gut.37.1.140","article-title":"Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity","volume":"37","author":"Kr\u00e4henb\u00fchl","year":"1995","journal-title":"Gut"},{"issue":"5\u20136","key":"10.1016\/j.clinre.2025.102529_bib0131","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1754.2005.00617.x","article-title":"Reye's syndrome developing in an infant on treatment of Kawasaki syndrome","volume":"41","author":"Wei","year":"2005","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"10.1016\/j.clinre.2025.102529_bib0132","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1023\/A:1005630218986","article-title":"Long-chain hydroxydicarboxylic aciduria, carnitine depletion and acetaminophen exposure","volume":"23","author":"Nowaczyk","year":"2000","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0133","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep.27265","article-title":"Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome","volume":"60","author":"McGill","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2025.102529_bib0134","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/path.1711170307","article-title":"Histopathological changes in the liver following a paracetamol overdose: correlation with clinical and biochemical parameters","volume":"117","author":"Portmann","year":"1975","journal-title":"J Pathol"},{"issue":"14","key":"10.1016\/j.clinre.2025.102529_bib0135","doi-asserted-by":"crossref","first-page":"7702","DOI":"10.3390\/ijms22147702","article-title":"Mitochondria matter: systemic aspects of nonalcoholic fatty liver disease (NAFLD) and diagnostic assessment of liver function by stable isotope dynamic breath tests","volume":"22","author":"Di Ciaula","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinre.2025.102529_bib0136","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116438","article-title":"Inhibition of PLA2G4A attenuated valproic acid- induced lysosomal membrane permeabilization and restored impaired autophagic flux: implications for hepatotoxicity","volume":"227","author":"Wang","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clinre.2025.102529_bib0137","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.114930","article-title":"Suppression of iron mobilization from lysosomes to mitochondria attenuates liver injury after acetaminophen overdose in vivo in mice: protection by minocycline","volume":"392","author":"Hu","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"issue":"12","key":"10.1016\/j.clinre.2025.102529_bib0138","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1016\/j.apsb.2021.09.023","article-title":"Recommendations for the use of the acetaminophen hepatotoxicity model for mechanistic studies and how to avoid common pitfalls","volume":"11","author":"Jaeschke","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0139","doi-asserted-by":"crossref","first-page":"e00211","DOI":"10.1002\/prp2.211","article-title":"Role of endoplasmic reticulum stress in drug-induced toxicity","volume":"4","author":"Foufelle","year":"2016","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.clinre.2025.102529_bib0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nutres.2024.01.013","article-title":"Kimchi attenuates endoplasmic reticulum stress-induced hepatic steatosis in HepG2 cells and C57BL\/6N mice","volume":"124","author":"Yun","year":"2024","journal-title":"Nutr Res"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0141","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","article-title":"A new perspective on NAFLD: focusing on lipid droplets","volume":"76","author":"Scorletti","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0142","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/a-2186-3557","article-title":"Mechanisms of lipid droplet accumulation in steatotic liver diseases","volume":"43","author":"Dempsey","year":"2023","journal-title":"Semin Liver Dis"},{"issue":"Pt A","key":"10.1016\/j.clinre.2025.102529_bib0143","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.fct.2017.08.020","article-title":"Induction of mitochondrial biogenesis protects against acetaminophen hepatotoxicity","volume":"108","author":"Du","year":"2017","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.clinre.2025.102529_bib0144","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-pathmechdis-051122-094016","article-title":"Acetaminophen hepatotoxicity: paradigm for understanding mechanisms of drug-induced liver injury","volume":"19","author":"Jaeschke","year":"2024","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"10.1016\/j.clinre.2025.102529_bib0145","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1528-1157.1988.tb03757.x","article-title":"Fatal liver failure in 16 children with valproate therapy","volume":"29","author":"Scheffner","year":"1988","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0146","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0168-8278(99)80020-8","volume":"30","author":"Chariot","year":"1999","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2025.102529_bib0147","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","article-title":"The multifaceted role of ferroptosis in liver disease","volume":"29","author":"Chen","year":"2022","journal-title":"Cell Death Differ"},{"issue":"6","key":"10.1016\/j.clinre.2025.102529_bib0148","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","article-title":"Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis","volume":"10","author":"Tsurusaki","year":"2019","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0149","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajpath.2019.09.011","article-title":"Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice","volume":"190","author":"Qi","year":"2020","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.clinre.2025.102529_bib0150","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41401-022-01010-5","article-title":"Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis","volume":"44","author":"Tong","year":"2023","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"10.1016\/j.clinre.2025.102529_bib0151","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2007-973710","article-title":"Valproate treatment induces lipid globule accumulation with ultrastructural abnormalities of mitochondria in skeletal muscle","volume":"28","author":"Melegh","year":"1997","journal-title":"Neuropediatrics"},{"issue":"8","key":"10.1016\/j.clinre.2025.102529_bib0152","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/501356","article-title":"Linezolid-induced inhibition of mitochondrial protein synthesis","volume":"42","author":"De Vriese","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinre.2025.102529_bib0153","article-title":"Epidemiology and risk determinants of drug-induced liver injury: current knowledge and future research needs","author":"Suzuki","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2025.102529_bib0154","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yrtph.2018.01.018","article-title":"Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury","volume":"94","author":"George","year":"2018","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.taap.2014.09.002","article-title":"Lower susceptibility of female mice to acetaminophen hepatotoxicity: role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase","volume":"281","author":"Du","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0156","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2025.102529_bib0157","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000638","article-title":"Uncovering undiagnosed liver disease: prevalence and opportunity for intervention in a population attending colonoscopy","volume":"8","author":"Koo","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"issue":"6","key":"10.1016\/j.clinre.2025.102529_bib0158","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/apt.15153","article-title":"Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis","volume":"49","author":"Regev","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.clinre.2025.102529_bib0159","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.celrep.2015.02.034","article-title":"Tetracyclines disturb mitochondrial function across eukaryotic models: a call for caution in biomedical research","volume":"10","author":"Moullan","year":"2015","journal-title":"Cell Rep"},{"issue":"8","key":"10.1016\/j.clinre.2025.102529_bib0160","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/jcm8081207","article-title":"Mitochondrial DNA variants in patients with liver injury due to anti-tuberculosis drugs","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.clinre.2025.102529_bib0161","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/17425255.2017.1252749","article-title":"Drug-induced liver injury: is chronic liver disease a risk factor and a clinical issue?","volume":"13","author":"Teschke","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clinre.2025.102529_bib0162","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tiv.2016.03.016","article-title":"A combined in vitro approach to improve the prediction of mitochondrial toxicants","volume":"34","author":"Eakins","year":"2016","journal-title":"Toxicol In Vitro"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125000099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125000099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T23:05:08Z","timestamp":1748127908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740125000099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":162,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2210740125000099"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102529","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial dysfunction in drug-induced hepatic steatosis: Recent findings and current concept","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102529"}}